Referent
Dr. Dr. Axel Hahn
Bundesinstitut für Risikobewertung (BfR) Berlin
(Gastgeber: Prof. Dr. K. Mottaghy)
Veranstaltungsort
Bibliothek der Institute für Physiologie, 6. Etage, neben D4, Raum 28
![[Translate to Englisch:]](/fileadmin/files/_processed_/6/1/csm_Prof._Stingl_Julia_9320_753c8df2f0.jpg "Univ.-Prof. Dr. med. Julia Stingl")
Univ.-Prof. Dr. med. Julia Stingl
Institute of Clinical Pharmacology
Previous
Next
- Team
- Research
- Research
- Clinical pharmacogenetic research
- Drug metabolism and kinetics
- Biophysical pharmacology of ion channels
- Biophysical pharmacology of ion channels
- Molecular Dynamics Guided Analysis of Ligand Activation, Ion Permeation and Subtype-specific Ligand Interactions in P2X Receptors
- Screening of approved drugs regarding their P2X3 receptor activity
- Functional characterization of heterologously expressed pain-related NaV mutants
- EISonION - Electrical Impedance Spectroscopy for drug screening on Ligand-gated ION channels
- Precision2Treat
- Drug therapy safety research
- Current third party funded projects
- Lehre
- Karriere
- Veranstaltungen
- Klinisch-pharmakologische Hochschulambulanz
- Kontakt & Anreise
